BLOG

Sunday, November 17, 2019

Glenmark Pharma jumps 9% after CLSA upgrades to 'buy' from 'sell'

In the last two sessions, the stock has zoomed over 16 per cent.

from Home Page https://ift.tt/33UlO64
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...